Vangl1 | VANGL planar cell polarity 1
Physiological systems
20 / 24 physiological systems tested
3 Significantly impacted by the knock-out
Homeostasis/metabolism Hematopoietic system Mortality/aging
17 No significant impact
4 Not tested
Data collections
Gene metrics:7Significant phenotypes
3Associated diseases
Expression examined in:45Adult tissues
0Embryo tissues
increased mean corpuscular hemoglobin | 1 supporting dataset | Vangl1tm1e(KOMP)Wtsi | heterozygote | Early adult | 7.56x10-5 | ||
increased circulating aspartate transaminase level | 1 supporting dataset | Vangl1tm1e(KOMP)Wtsi | heterozygote | Early adult | 8.34x10-5 | ||
preweaning lethality, incomplete penetrance | 1 supporting dataset | Vangl1tm1e(KOMP)Wtsi | homozygote | Early adult | N/A * | ||
thrombocytosis | 1 supporting dataset | Vangl1tm1e(KOMP)Wtsi | heterozygote | Early adult | 9.9x10-5 |
| | | | | | | | | |
External links
No external links available for Vangl1.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Vangl1tm1a(KOMP)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
Vangl1tm1e(KOMP)Wtsi | Targeted, non-conditional allele | | ES Cell mouse |
Vangl1tm2a(KOMP)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
Vangl1tm2e(KOMP)Wtsi | Targeted, non-conditional allele | | ES Cell |